CD8 + T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis

Journal of Immunology

Volumn 189, Issue 1, 2012, Pages 425-432

  Conrady, Christopher D ^a   Zheng, Min ^a   Stone, Donald U ^a   Carr, Daniel J J ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; VASCULOTROPIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; CORNEA VASCULARIZATION; DISEASE SEVERITY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; IMMUNOPATHOGENESIS; LYMPHANGIOGENESIS; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; SLIT LAMP; TISSUE DISTRIBUTION; VIRUS INHIBITION; VIRUS REPLICATION; WILD TYPE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL MOVEMENT; CERCOPITHECUS AETHIOPS; FEMALE; HERPESVIRUS 1, HUMAN; KERATITIS, HERPETIC; LYMPH NODES; LYMPHANGIOGENESIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VIRUS REPLICATION;

EID: 84862860972     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1200063     Document Type: Article

References (47)

1. Xu, F., M. R. Sternberg, B. J. Kottiri, G. M. McQuillan, F. K. Lee, A. J. Nahmias, S. M. Berman, and L. E. Markowitz. 2006. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296: 964-973. (Pubitemid 44285373)
2. Khanna, K. M., A. J. Lepisto, and R. L. Hendricks. 2004. Immunity to latent viral infection: many skirmishes but few fatalities. Trends Immunol. 25: 230-234. (Pubitemid 38501668)
3. Conrady, C. D., D. A. Drevets, and D. J. Carr. 2010. Herpes simplex type I (HSV-1) infection of the nervous system: is an immune response a good thing? J. Neuroimmunol. 220: 1-9.
4. Carr, D. J., P. Härle, and B. M. Gebhardt. 2001. The immune response to ocular herpes simplex virus type 1 infection. Exp. Biol. Med. (Maywood) 226: 353-366. (Pubitemid 32506362)
5. Liesegang, T. J. 1989. Epidemiology of ocular herpes simplex. Natural history in Rochester, Minn, 1950 through 1982. Arch. Ophthalmol. 107: 1160-1165. (Pubitemid 19195643)
6. Yan, X. T., T. M. Tumpey, S. L. Kunkel, J. E. Oakes, and R. N. Lausch. 1998. Role of MIP-2 in neutrophil migration and tissue injury in the herpes simplex virus-1-infected cornea. Invest. Ophthalmol. Vis. Sci. 39: 1854-1862.
7. Duan, R., L. Remeijer, J. M. van Dun, A. D. Osterhaus, and G. M. Verjans. 2007. Granulocyte macrophage colony-stimulating factor expression in human herpetic stromal keratitis: implications for the role of neutrophils in HSK. Invest. Ophthalmol. Vis. Sci. 48: 277-284. (Pubitemid 47251414)
8. Doymaz, M. Z., and B. T. Rouse. 1992. Herpetic stromal keratitis: an immunopathologic disease mediated by CD4+ T lymphocytes. Invest. Ophthalmol. Vis. Sci. 33: 2165-2173.
9. Banerjee, K., P. S. Biswas, U. Kumaraguru, S. P. Schoenberger, and B. T. Rouse. 2004. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. J. Immunol. 173: 7575-7583. (Pubitemid 39628199)
10. Koelle, D. M., S. N. Reymond, H. Chen, W. W. Kwok, C. McClurkan, T. Gyaltsong, E. W. Petersdorf, W. Rotkis, A. R. Talley, and D. A. Harrison. 2000. Tegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans. J. Virol. 74: 10930-10938. (Pubitemid 32223957)
11. Bonina, L., A. A. Nash, A. Arena, K. N. Leung, and P. Wildy. 1984. T cell-macrophage interaction in arginase-mediated resistance to herpes simplex virus. Virus Res. 1: 501-505. (Pubitemid 14047974)
12. Knickelbein, J. E., K. M. Khanna, M. B. Yee, C. J. Baty, P. R. Kinchington, and R. L. Hendricks. 2008. Noncytotoxic lytic granule-mediated CD8+ T cell inhibition of HSV-1 reactivation from neuronal latency. Science 322: 268-271.
13. Conrady, C. D., M. Thapa, T. Wuest, and D. J. Carr. 2009. Loss of mandibular lymph node integrity is associated with an increase in sensitivity to HSV-1 infection in CD118-deficient mice. J. Immunol. 182: 3678-3687.
14. Banerjee, K., P. S. Biswas, and B. T. Rouse. 2005. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J. Leukoc. Biol. 77: 24-32. (Pubitemid 40310689)
15. Hendricks, R. L., and T. M. Tumpey. 1991. Concurrent regeneration of T lymphocytes and susceptibility to HSV-1 corneal stromal disease. Curr. Eye Res. 10(Suppl): 47-53.
16. Stuart, P. M., B. Summers, J. E. Morris, L. A. Morrison, and D. A. Leib. 2004. CD8(+) T cells control corneal disease following ocular infection with herpes simplex virus type 1. J. Gen. Virol. 85: 2055-2063. (Pubitemid 39023285)
17. Nakanishi, Y., B. Lu, C. Gerard, and A. Iwasaki. 2009. CD8(+) T lymphocyte mobilization to virus-infected tissue requires CD4(+) T-cell help. Nature 462: 510-513.
18. Rajasagi, N. K., S. H. Kassim, C. M. Kollias, X. Zhao, R. Chervenak, and S. R. Jennings. 2009. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1. J. Virol. 83: 5256-5268.
19. Ghiasi, H., S. Cai, G. C. Perng, A. B. Nesburn, and S. L. Wechsler. 2000. Both CD4+ and CD8+ T cells are involved in protection against HSV-1 induced corneal scarring. Br. J. Ophthalmol. 84: 408-412. (Pubitemid 30255492)
20. Mueller, S. N., W. Heath, J. D. McLain, F. R. Carbone, and C. M. Jones. 2002. Characterization of two TCR transgenic mouse lines specific for herpes simplex virus. Immunol. Cell Biol. 80: 156-163. (Pubitemid 34298088)
21. van Lint, A., M. Ayers, A. G. Brooks, R. M. Coles, W. R. Heath, and F. R. Carbone. 2004. Herpes simplex virus-specific CD8+ T cells can clear established lytic infections from skin and nerves and can partially limit the early spread of virus after cutaneous inoculation. J. Immunol. 172: 392-397. (Pubitemid 38020493)
22. Wareing, M. D., A. B. Lyon, B. Lu, C. Gerard, and S. R. Sarawar. 2004. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice. J. Leukoc. Biol. 76: 886-895. (Pubitemid 39313726)
23. Conrady, C. D., H. Jones, M. Zheng, and D. J. J. Carr. 2011. A functional type I interferon pathway drives resistance to cornea herpes simplex virus type 1 infection by recruitment of leukocytes. J Biomed Res 25: 111-119.
24. Conrady, C. D., W. P. Halford, and D. J. Carr. 2011. Loss of the type I interferon pathway increases vulnerability of mice to genital herpes simplex virus 2 infection. J. Virol. 85: 1625-1633.
25. Wuest, T. R., and D. J. Carr. 2010. VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis. J. Exp. Med. 207: 101-115.
26. Wuest, T. R., and D. J. Carr. 2008. Dysregulation of CXCR3 signaling due to CXCL10 deficiency impairs the antiviral response to herpes simplex virus 1 infection. J. Immunol. 181: 7985-7993.
27. Christensen, J. E., C. de Lemos, T. Moos, J. P. Christensen, and A. R. Thomsen. 2006. CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system. J. Immunol. 176: 4235-4243. (Pubitemid 44264402)
28. Thapa, M., R. S. Welner, R. Pelayo, and D. J. Carr. 2008. CXCL9 and CXCL10 expression are critical for control of genital herpes simplex virus type 2 infection through mobilization of HSV-specific CTL and NK cells to the nervous system. J. Immunol. 180: 1098-1106.
29. Wuest, T., M. Zheng, S. Efstathiou, W. P. Halford, and D. J. J. Carr. 2011. The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization. PLoS Pathog. 7: e1002278.
30. Olsson, A. K., A. Dimberg, J. Kreuger, and L. Claesson-Welsh. 2006. VEGF receptor signalling - in control of vascular function. Nat. Rev. Mol. Cell Biol. 7: 359-371.
31. Mor, F., F. J. Quintana, and I. R. Cohen. 2004. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J. Immunol. 172: 4618-4623. (Pubitemid 38375280)
32. Maertzdorf, J., G. M. Verjans, L. Remeijer, A. van der Kooi, and A. D. Osterhaus. 2003. Restricted T cell receptor beta-chain variable region protein use by cornea-derived CD4+ and CD8+ herpes simplex virus-specific T cells in patients with herpetic stromal keratitis. J. Infect. Dis. 187: 550-558. (Pubitemid 36250018)
33. Lepisto, A. J., G. M. Frank, M. Xu, P. M. Stuart, and R. L. Hendricks. 2006. CD8 T cells mediate transient herpes stromal keratitis in CD4-deficient mice. Invest. Ophthalmol. Vis. Sci. 47: 3400-3409. (Pubitemid 351639704)
34. Divito, S. J., and R. L. Hendricks. 2008. Activated inflammatory infiltrate in HSV-1-infected corneas without herpes stromal keratitis. Invest. Ophthalmol. Vis. Sci. 49: 1488-1495.
35. Xu, M., A. J. Lepisto, and R. L. Hendricks. 2004. CD154 signaling regulates the Th1 response to herpes simplex virus-1 and inflammation in infected corneas. J. Immunol. 173: 1232-1239. (Pubitemid 38924301)
36. Ambati, B. K., M. Nozaki, N. Singh, A. Takeda, P. D. Jani, T. Suthar, R. J. Albuquerque, E. Richter, E. Sakurai, M. T. Newcomb, et al. 2006. Corneal avascularity is due to soluble VEGF receptor-1. Nature 443: 993-997. (Pubitemid 44646176)
37. Lim, L., K. Pesudovs, and D. J. Coster. 2000. Penetrating keratoplasty for keratoconus: visual outcome and success. Ophthalmology 107: 1125-1131.
38. Epstein, R. J., J. A. Seedor, N. G. Dreizen, R. D. Stulting, G. O. Waring, III, L. A. Wilson, and H. D. Cavanagh. 1987. Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival. Ophthalmology 94: 935-944. (Pubitemid 17144492)
39. Pavan-Langston, D., and M. B. Abelson. 1978. Glucocorticoid therapy in ocular herpes simplex. II. Advantages. Surv. Ophthalmol. 23: 35, 43-47.
40. Saravia, M., G. Zapata, P. Ferraiolo, L. Racca, and A. Berra. 2009. Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis. Graefes Arch. Clin. Exp. Ophthalmol. 247: 1409-1416.
41. de Nadaï, P., C. Chenivesse, J. Gilet, H. Porte, H. Vorng, Y. Chang, A. F. Walls, B. Wallaert, A. B. Tonnel, A. Tsicopoulos, and H. G. Zerwes. 2006. CCR5 usage by CCL5 induces a selective leukocyte recruitment in human skin xenografts in vivo. J. Invest. Dermatol. 126: 2057-2064.
42. Dufour, J. H., M. Dziejman, M. T. Liu, J. H. Leung, T. E. Lane, and A. D. Luster. 2002. IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking. J. Immunol. 168: 3195-3204. (Pubitemid 34256349)
43. Wendel, M., I. E. Galani, E. Suri-Payer, and A. Cerwenka. 2008. Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res. 68: 8437-8445.
44. Zhang, B., Y. K. Chan, B. Lu, M. S. Diamond, and R. S. Klein. 2008. CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis. J. Immunol. 180: 2641-2649.
45. Thapa, M., and D. J. Carr. 2009. CXCR3 deficiency increases susceptibility to genital herpes simplex virus type 2 infection: Uncoupling of CD8+ T-cell effector function but not migration. J. Virol. 83: 9486-9501.
46. Carr, D. J., T. Wuest, and J. Ash. 2008. An increase in herpes simplex virus type 1 in the anterior segment of the eye is linked to a deficiency in NK cell infiltration in mice deficient in CXCR3. J. Interferon Cytokine Res. 28: 245-251. (Pubitemid 351591449)
47. Lundberg, P., H. Openshaw, M. Wang, H. J. Yang, and E. Cantin. 2007. Effects of CXCR3 signaling on development of fatal encephalitis and corneal and periocular skin disease in HSV-infected mice are mouse-strain dependent. Invest. Ophthalmol. Vis. Sci. 48: 4162-4170. (Pubitemid 351261044)